Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Ranbaxy Metformin Product Recall (2020-02-26)
- Starting date:
- February 26, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-72455
Last updated:
Summary
-
Product:
- RAN-Metformin 850 mg Tablet
- RAN-Metformin 500 mg Tablet
- RAN-Metformin 850 mg Tablet
- RAN-Metformin 500 mg Tablet
Reason
Presence of N-nitrosodimethylamine (NDMA) above or near the interim acceptable concentration limit in affected lot(s).
Depth of distribution
Wholesalers, Healthcare Establishments, Retailers
Affected products
-
RAN-Metformin 850 mg Tablet
DIN, NPN, DIN-HIM
DIN 02269058Dosage form
Tablet
Strength
Meformin hydrochloride 850 mg
Lot or serial number
AJZ8005A
Companies
- Recalling Firm
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
- Marketing Authorization Holder
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
B. RAN-Metformin 500 mg Tablet
DIN, NPN, DIN-HIM
DIN 02269031Dosage form
Tablet
Strength
Meformin hydrochloride 500 mg
Lot or serial number
AJY8006A, AJY8007A, AJY8005A, AJY8005B, AJY8008A
Companies
- Recalling Firm
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
- Marketing Authorization Holder
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
For more information
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72287a-eng.php- Date modified: